CLINICAL_TRIALS
trial_result
· 2017-10-12
Clinical Trial Update: Effects of Genmont Probiotic on Improve the Level of Blood Glucose and Other Diabetic Associate Parameter in Type 2 Diabetes Patients [Phase 2]
Summary
Phase 2 trial evaluating Genmont Probiotic on blood glucose and other diabetes-related parameters in adults with Type 2 diabetes mellitus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GenMont Biotech Incorporation | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED